|
Market Closed -
Other stock markets
|
After hours 19:55:22 | |||
| 208.46 USD | -3.54% |
|
210.52 | +0.99% |
| 07-06 | HSBC Adjusts Price Target on Biogen to $157 From $150 | MT |
| 07-01 | Biogen Says Research, Milestone Charges to Reduce Earnings in Q2, Q3 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 30.78B | |||||
| 66.11B | |||||
| 55.3B | |||||
| 42.44B | |||||
| 41.28B | - | ||||
| 32.46B | - |
- Stock Market
- Stocks
- BIIB Stock
- Charts Biogen Inc.
- Sector Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
